Clinical Trial

Guo's Subclavian Artery Reconstruction: The Prospective, Multiple Center Study of WeFlow-Tbranch Stent Graft System(GUEST Study)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multiple center study to evaluate the safety and effectiveness of WeFlow-Tbranch single embedded branch thoracic aorta stent graft system manufactured by EndoNom Medtech (Hangzhou) Co., Ltd.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-02-19; most recent amendment 2024-04-28.
Status change: Recruiting → Active, Not Recruiting 2023-08-27
Trial Details
NCT Number NCT04765605
Lead Sponsor Hangzhou Endonom Medtech Co., Ltd.
Conditions Type B Aortic Dissection
Enrollment 120 participants
Start Date 2020-12-25
Primary Completion 2026-12-25 (estimated)
Study Completion 2026-12-25 (estimated)
Updated on ClinicalTrials.gov 2024-04-30